Axolot Solutions (AXOLOT) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Net sales for Q2 2024 were 966 tkr, down from 1,182 tkr in Q2 2023, mainly from commercial installations, service, and demo activities.
Operating result for Q2 2024 was -5,210 tkr, impacted by continued optimization work and increased personnel costs due to a new CEO.
Net result per share for Q2 2024 was -0.03 kr, compared to -0.04 kr in Q2 2023.
Cash flow from operations and investments in Q2 2024 was -4,470 tkr; cash at period end was 6,437 tkr.
After Q2, a directed share issue and credit facility were secured to fund strategic projects and market expansion.
Financial highlights
Net sales for H1 2024 increased to 4,316 tkr from 2,491 tkr in H1 2023, mainly from AxoPur installations and related services.
Operating result for H1 2024 was -10,564 tkr, compared to -8,725 tkr in H1 2023; higher costs due to process optimization and quality work.
Net result for H1 2024 was -10,535 tkr, compared to -8,766 tkr in H1 2023.
Cash at end of June 2024 was 6,437 tkr, down from 16,968 tkr at year-end 2023.
Equity at period end was 11,155 tkr, compared to 15,852 tkr at June 2023.
Outlook and guidance
Several strategic collaborations and customer projects are planned for the autumn, focusing on PFAS and microplastics solutions.
Market interest is increasing due to stricter EU BAT-AEL requirements and heightened awareness of PFAS and microplastics issues.
Expansion into the Norwegian fish processing industry is ongoing, though delayed by regulatory approvals.
Management remains optimistic about a market breakthrough, supported by new partnerships and product innovations.
Latest events from Axolot Solutions
- Revenue surged in 2025, supported by expansion and key partnerships, despite a net loss.AXOLOT
Q4 202511 Feb 2026 - Sales and operating results improved in Q3 2025, with accelerated international expansion.AXOLOT
Q3 202528 Oct 2025 - Order growth, international expansion, and regulatory tailwinds drive positive Q2 momentum.AXOLOT
Q2 202529 Jul 2025 - Q3 sales surged, but losses deepened as Axolot completed a transformative merger with Mellifiq.AXOLOT
Q3 202413 Jun 2025 - Q1 2025 saw Axolot's sales surge and key PFAS contracts secured via partner expansion.AXOLOT
Q1 20256 Jun 2025 - Strategic shift and major partnership drive Axolot's growth prospects despite 2024 losses.AXOLOT
Q4 20245 Jun 2025